Xeljanz Tablet, Film Coated
Pricing Report NDC 0069-1001-01

Current NADAC: $73.77164 per EA · Effective Sep 23, 2026 · Est. package price $4,426.30 (60 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Xeljanz (NDC 0069-1001-01) is $73.77164 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Pfizer Laboratories Div Pfizer Inc, this medication is distributed in a 60 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$73.77164
Per EA

Effective Date
Sep 23, 2026
Billable Units
60 EA
Estimated Package Price
$4,426.30
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
60 TABLET, FILM COATED in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.57264 (Effective: Sep 02, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2013, the NADAC wholesale price for (NDC ) has moved within a range of $33.28719 to $98.59050 per EA. Over this 13 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$33.2872 - $98.5905
Market Volatility
196.18% Variance
Latest Trend
0.14%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $73.77164 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $73.66576 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $73.66576 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $73.73221 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $73.57261 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $73.67146 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $73.83291 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $73.83291 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $73.83291 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $98.44389 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $98.45378 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $98.40259 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026